The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Preliminary evidence for hdv exposure in apparently non-HBV-infected patients
Hepatology. 2020 Jul 6. doi: 10.1002/hep.31453. Online ahead of print.
Isabelle Chemin1, Flor H Pujol2, Caroline Scholtès13, Carmen L Loureiro2, Fouzia Amirache4, Massimo Levrero15, Fabien Zoulim15, Jimena Pérez-Vargas4, François-Loïc Cosset4
Author information
1Cancer Research Center of Lyon (CRCL), UMR Inserm 1052 - CNRS 5286 mixte CLB - UCBL1, F- 69008, Lyon, France.
3Laboratoire de Virologie, Groupement Hospitalier Nord, Institut des Agents Infectieux, CBN, Hospices Civil de Lyon, F- 69004, Lyon, France.
4CIRI, Centre International de Recherche en Infectiologie, Team EVIR, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France.
5Department of Hepatology, Hôpital de la Croix Rousse, Hospices Civil de Lyon, F- 69004, Lyon, France.
Abstract
Hepatitis delta virus (HDV) is a defective human virus that lacks the ability to produce its own envelope proteins and is thus dependent on the presence of a helper virus, which provides its surface proteins to produce infectious particles. Hepatitis B virus (HBV) was so far thought to be the only helper virus described to be associated to HDV. However, recent studies showed that divergent HDV-like viruses can be detected in fishes, birds, amphibians, and invertebrates, without evidence of any HBV-like agent supporting infection.